Peer Review History

Original SubmissionJune 15, 2019
Decision Letter - Hélène Carabin, Editor, Adam Akullian, Editor

Dear Dr. Ali:

Thank you very much for submitting your manuscript "Identification of cholera hotspots in Zambia: A spatiotemporal analysis of cholera data from 2008 to 2017" (#PNTD-D-19-00964) for review by PLOS Neglected Tropical Diseases. Your manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised some substantial concerns about the manuscript as it currently stands. These issues must be addressed before we would be willing to consider a revised version of your study. We cannot, of course, promise publication at that time.

We therefore ask you to modify the manuscript according to the review recommendations before we can consider your manuscript for acceptance. Your revisions should address the specific points made by each reviewer.

When you are ready to resubmit, please be prepared to upload the following:

(1) A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

(2) Two versions of the manuscript: one with either highlights or tracked changes denoting where the text has been changed (uploaded as a "Revised Article with Changes Highlighted" file); the other a clean version (uploaded as the article file).

(3) If available, a striking still image (a new image if one is available or an existing one from within your manuscript). If your manuscript is accepted for publication, this image may be featured on our website. Images should ideally be high resolution, eye-catching, single panel images; where one is available, please use 'add file' at the time of resubmission and select 'striking image' as the file type.

Please provide a short caption, including credits, uploaded as a separate "Other" file. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License at http://journals.plos.org/plosntds/s/content-license (NOTE: we cannot publish copyrighted images).

(4) If applicable, we encourage you to add a list of accession numbers/ID numbers for genes and proteins mentioned in the text (these should be listed as a paragraph at the end of the manuscript). You can supply accession numbers for any database, so long as the database is publicly accessible and stable. Examples include LocusLink and SwissProt.

(5) To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plosntds/s/submission-guidelines#loc-methods

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

We hope to receive your revised manuscript by Jan 31 2020 11:59PM. If you anticipate any delay in its return, we ask that you let us know the expected resubmission date by replying to this email.

To submit a revision, go to https://www.editorialmanager.com/pntd/ and log in as an Author. You will see a menu item call Submission Needing Revision. You will find your submission record there.

Sincerely,

Adam Akullian, Ph.D.

Associate Editor

PLOS Neglected Tropical Diseases

Hélène Carabin

Deputy Editor

PLOS Neglected Tropical Diseases

***********************

Please also address the following re: case definition on lines 105-109. The case definition is unclear. Please describe the inclusion / exclusion criteria for cases, including age-restrictions and whether cases needed to be culture confirmed or just "suspected." Also, it appears that patients under 5 were not included in the study. Please explain and consider adding this as a limitation. The word, "should" on line 108 suggests the case definition may have not been followed. Please comment.

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: This is a straightforward study with clearly defined aims and appropriate statistical methodologies employed.

The cholera data section does not explicitly state the spatial resolution of the confirmed/suspected cases until the ethical section. Would it be possible to combine these sections or have the ethical section come immediately after? The cholera data feels lacking in detail about the spatial resolution of the data otherwise.

It would also be helpful if the section on population factors (lines 111-115) described the variables used in more detail rather than requiring the reader to wait for the table in the results section.

Reviewer #2: The objectives of the study was clearly stated, however the data sources and statistical analysis are not well described.

Are the cholera data used in this study monthly or yearly and at district level? Please explicitly state the level(s) in which the data was collected.

The authors provided a generic description of Zero Inflated Negtative Binomial model but did not explicitly relate the model to the current study. They mentioned that “y” is the independent variable. They should clearly state whether it is the counts of cholera cases in each district at a particular time (yearly?). In formulating the model, subscript should be used to allow the reader follow the methods easily.

Line 137: Provide reference for SaTScan.

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: The analysis of results is equally straightforward as the methods, although I have a few questions:

It is unclear what the numbers on the bars represent in Figure 1, as they do not seem to match the numbers mentioned in the preceding text.

The peak in 2009/2010 is striking. Do the authors have access to enough temporally refined data to study why this was the case, in terms of environmental/socio-economic factors? It would be helpful at least for the authors to discuss potential underlying reasons for this peak and then relative decline.

This leads me to also wonder if the hotspots found might differ if the authors split the data into, say, two groups - pre- and post-2010 and then re-ran their analysis on these two different time periods.

Figure 5 is of somewhat low resolution/quality.

Reviewer #2: The annotation in Figure 1 is not clear. What does the number on each bar represents? It does not correspond to the numbers on the y axis.

The maps in Figure 2 are too small. Change the format to 2 maps per row (5 by 2).

Table 2: Why is N=72? Since your study is spatiotemporal, you should have more data points than 72 districts times time. Were the 2008-2017 data sets aggregated for ZINB model?

On line 261, the authors said that “Distance from waterbodies” was the only significant variable. I will be cautious in reporting this as such, the confidence interval in Table 3 did not support this claim.

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: Conclusions and limitations are clearly presented and supported by the study, so I have no major comments here.

Reviewer #2: The limitation should also include the use of a single (year) survey, ZDHS 2014 to extract the WASH data when the study period is 2008-2017.

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: Some editorial modifications are needed throughout, where words are missing for example.

Reviewer #2: The manuscript "Identification of cholera hotspots in Zambia: A spatiotemporal analysis of cholera data from 2008 to 2017” will require full language edits. There are grammatical and orthographic errors here and there.

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: As per my comments above, I find this to be a straightforward study which is of use for Zambian public health efforts to reduce the burden of cholera. My suggestions have been mainly to explore other ways of dividing the data to see if conclusions remain the same. It would be very interesting to see future work include data from the surrounding countries and look into human movement patterns across and within national boundaries to see how these are affecting the persistence of cholera in the region as a whole.

Reviewer #2: My major concern with this manuscript is the statistical methods used. Rather than using a range of regression models, a multilevel model (ZINB or ZIP with random effects) will suffice. The spatial heterogeneity of the cholera outbreaks will be captured by the random effects. Alternatively, a spatial ZINB or ZIP can be used with a spatially correlated errors.

See for example, Loquiha O, Hens N, Chavane L, Temmerman M, Osman N, Faes C, Aerts M. Mapping maternal mortality rate via spatial zero-inflated models for count data: A case study of facility-based maternal deaths from Mozambique. PloS one. 2018 Nov 9;13(11):e0202186.

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Revision 1

Attachments
Attachment
Submitted filename: Responses to the reviewers comments.docx
Decision Letter - Hélène Carabin, Editor, Adam Akullian, Editor

Dear Dr. Ali,

Thank you very much for submitting your manuscript "Identification of cholera hotspots in Zambia: A spatiotemporal analysis of cholera data from 2008 to 2017" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.  

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. 

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Adam Akullian, Ph.D.

Associate Editor

PLOS Neglected Tropical Diseases

Hélène Carabin

Deputy Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: The objectives of the study are clearly stated and straightforward, and the types statistical analyses are appropriate. However, I have a few questions and concerns about the data and study design:

Cholera data: What effect might the inclusion of suspected cases have on the analysis, particularly if the goal of the study is to identify vaccine targets rather than zones where sanitation improvements are needed? Are there not other water-borne pathogens in the country?

It also isn’t clear why cases were included for patients 5 years or older from areas where cholera was not known to have occurred. What is the justification behind this decision?

Population and socioeconomic data: In the introduction, the authors state that it is particularly peri-urban areas that are at highest risk for cholera transmission in Zambia. Would it be possible to further refine urban/rural classifications as such? It seems it would be important to identify and target not only those districts which are at risk, but specifically the peri-urban zones within these districts.

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: Figure 1 – Does this figure represent confirmed cases alone, or both confirmed and suspected? It would be good to distinguish between the two in the figure. Furthermore, it seems as though cholera rates have declined overall since the peak in 2010. Can the authors comment on the reasons underlying this pattern? Given this pattern, it would be interesting to see analyses that focus on the data from recent years and compare it to the distribution of previous years. Have the patterns changed, or do they remain the same as for the peak years? If they have changed, what are the implications for vaccine targeting?

Figure 2 -There appears to be a colour in the map that is not represented in the legend (green).

Results – paragraph beginning Line 263: It is interesting to see that some wards were not hotspots within districts, and is pertinent to my comment about identifying peri-urban areas above. Were these wards peri-urban?

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: Conclusions are well supported by the data, and limitations are addressed albeit briefly. There is clear public health relevance of this study, but maps showing specific wards that should be targeted for vaccines would make this even clearer. Especially if the goal is specifically to focus limited vaccine resources.

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: There are minor edits needed throughout for missing words and clarity.

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: This paper is of public health interest for Zambia, and has implications for global cholera control as well. I believe it will be even stronger if analyses are split by time period (distinguishing recent years), and if greater attention is paid to ward-level outputs and peri-urban status.

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plosntds/s/submission-guidelines#loc-materials-and-methods

Revision 2

Attachments
Attachment
Submitted filename: Responses to the Reviewers comments_R2.docx
Decision Letter - Hélène Carabin, Editor, Adam Akullian, Editor

Dear Dr. Ali,

We are pleased to inform you that your manuscript 'Identification of cholera hotspots in Zambia: A spatiotemporal analysis of cholera data from 2008 to 2017' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Adam Akullian, Ph.D.

Associate Editor

PLOS Neglected Tropical Diseases

Hélène Carabin

Deputy Editor

PLOS Neglected Tropical Diseases

***********************************************************

Formally Accepted
Acceptance Letter - Hélène Carabin, Editor, Adam Akullian, Editor

Dear Dr. Ali,

We are delighted to inform you that your manuscript, "Identification of cholera hotspots in Zambia: A spatiotemporal analysis of cholera data from 2008 to 2017," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Serap Aksoy

Editor-in-Chief

PLOS Neglected Tropical Diseases

Shaden Kamhawi

Editor-in-Chief

PLOS Neglected Tropical Diseases

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .